Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SFX‐01 to enter Phase II/III trials to test efficacy against COVID-19 symptoms

europeanpharmaceuticalreviewJune 19, 2020

Tag: SFX‐01 , COVID-19 , ARDS , Evgen Pharma , Nrf2

PharmaSources Customer Service